drugset / Trial / NCT04395768
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
RandomizedParallel-groupDouble-blindTreatment
Summary
COVID-19 is a global pandemic. So far encouraging results have been shown in different parts of the world with the utilisation of hydroxycloroquine, zinc, and azithromycin, and early studies into some of these, plus some with Vitamin C, have also proven beneficial. Vitamin D levels have also been shown to be an important indicator to the severity of symptoms in COVID-19 patients.
Timeline
- Start
- 2020-09-09
- Primary completion
- 2021-09-30
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 250 mg | Oral |
| Subject | Hydroxychloroquine | Small molecule | 200 mg | Oral |